Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 27, 2018 - Indivior and Durect announced the FDA approval of Perseris (risperidone), for the treatment of schizophrenia in adults.
Download PDF
Return to publications
